Journal info


6 times a year.
Founded: 1954
ISSN 0028-2685
ISSN 1338-4317 (online)

Published in English

Editorial Info
Abstracted and Indexed
Submission Guidelines

Select Journal







Webshop Cart

Your Cart is currently empty.

Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.

2022

Mast cells as a tumor microenvironment factor associated with the aggressiveness of prostate cancer
Authors: Taras ZADVORNYI, Natalia LUKIANOVA, Tetiana BORIKUN, Andrii TYMOSHENKO, Oleksandr MUSHII, Olena VORONINA, Iurii VITRUK, Eduard STAKHOVSKYI, Vasyl CHEKHUN
Neoplasma Vol.69, No.6, p. 1490–1498, 2022
doi:10.4149/neo_2022_221014N1020
Price: free access
[View Abstract]


Clinical characteristics and prognostic value of EGFR mutation in stage I lung adenocarcinoma with spread through air spaces after surgical resection
Authors: Mao-Gang GAO, Shi-Ze WANG, Kai-Hong HAN, Shao-Nan XIE, Qing-Yi LIU
Neoplasma Vol.69, No.6, p. 1480–1489, 2022
doi:10.4149/neo_2022_220619N649
Price: free access
[View Abstract]


Real-world evidence of efficacy and safety of pomalidomide and dexamethasone in relapsed/refractory multiple myeloma patients: Czech registry data
Authors: Viera SANDECKA, Luděk POUR, Ivan ŠPIČKA, Jiří MINAŘÍK, Jakub RADOCHA, Tomáš JELÍNEK, Petr PAVLÍČEK, Alexandra JUNGOVÁ, Petr KESSLER, Marek WRÓBEL, Martin ŠTORK, Jan ŠTRAUB, Tomáš PIKA, Lenka ČÁPKOVÁ, Sabina ŠEVČÍKOVÁ, Vladimír MAISNAR, Roman HÁJEK
Neoplasma Vol.69, No.6, p. 1474–1479, 2022
doi:10.4149/neo_2022_220813N827
Price: free access
[View Abstract]


Burkitt lymphoma-a retrospective analysis of data from the Registry of the Czech Lymphoma Study Group with external validation of the Burkitt lymphoma International Prognostic Index
Authors: Alice SÝKOROVÁ, Vít PROCHÁZKA, Heidi MÓCIKOVÁ, Andrea JANÍKOVÁ, Robert PYTLÍK, David BELADA, Kateřina BENEŠOVÁ, Pavel KLENER Jr., Juraj ĎURAŠ, Lukáš SMOLEJ, Vít CAMPR, Petra BLAHOVCOVÁ, Marek TRNĚNÝ
Neoplasma Vol.69, No.6, p. 1466–1473, 2022
doi:10.4149/neo_2022_221030N1064
Price: free access
[View Abstract]


Correlation between gastritis cystica profunda and the risk of lymph node metastasis in early gastric cancer
Authors: Jia-Jia WU, Yu-Qing CHENG, Hao-Jun YANG, Min LIN
Neoplasma Vol.69, No.6, p. 1459–1465, 2022
doi:10.4149/neo_2022_220314N281
Price: free access
[View Abstract]


Evaluation of serum glucose-regulated protein 78 (GRP78) as a biomarker of treatment response to bortezomib-based induction regimen in multiple myeloma: A cross-sectional pilot study
Authors: Suganthi Sekaran RAMACHANDRAN, Pooja GUPTA, Lalit KUMAR, Ritu GUPTA, Lavisha GOEL, Vijay Lakshmi KUMAR, Yogendra Kumar GUPTA
Neoplasma Vol.69, No.6, p. 1451–1458, 2022
doi:10.4149/neo_2022_220526N564
Price: free access
[View Abstract]


Safety and efficacy of the FLOT regimen in the Polish population - an analysis of the prospective trial
Authors: Katarzyna Marcisz-Grzanka, Mariola Winiarek, Jakub Pałucki, Paulina Wieszczy, Tomasz Olesiński, Mariusz Jóźwiak, Radosław Samsel, Urszula Sułkowska, Agnieszka Kolasińska-Ćwikła, Lucjan Stanisław Wyrwicz
Neoplasma Vol.69, No.6, p. 1445–1450, 2022
doi:10.4149/neo_2022_220720N734
Price: free access
[View Abstract]


The prognostic impact of immune checkpoint inhibitors for the treatment of pulmonary sarcomatoid carcinoma: A multicenter retrospective study
Authors: Jing-Wen Wei, Yue Hao, Jing Xiang, Xing-Xiang Pu, Li-Ping Wang, Zhan-Sheng Jiang, Jing-Xun Wu, Qian Wang, Chun-Wei Xu, Wen-Xian Wang, Zheng-Bo Song
Neoplasma Vol.69, No.6, p. 1437–1444, 2022
doi:10.4149/neo_2022_220617N644
Price: free access
[View Abstract]


Moderately hypofractionated salvage radiotherapy in patients with biochemical recurrence of prostate cancer after prostatectomy: long-term results and comparative analysis of two schedules
Authors: Fabio Matrone, Alessandra Donofrio, Giuseppe Fanetti, Alberto Revelant, Jerry Polesel, Paola Chiovati, Roberto Bortolus
Neoplasma Vol.69, No.6, p. 1425–1436, 2022
doi:10.4149/neo_2022_220825N864
Price: free access
[View Abstract]


TLR2 and TLR4 in colorectal cancer: relationship to tumor necrosis and markers of systemic inflammation
Authors: Karoliina Paarnio, Juha P Väyrynen, Sara A Väyrynen, Tiina Kantola, Timo Karhu, Taina Tervahartiala, Kai Klintrup, Timo Sorsa, Tuula Salo, Jyrki Mäkelä, Tuomo J Karttunen
Neoplasma Vol.69, No.6, p. 1418–1424, 2022
doi:10.4149/neo_2022_220509N498
Price: free access
[View Abstract]


LncRNA CBR3-AS1 predicts a poor prognosis and promotes cervical cancer progression through the miR-3163/LASP1 pathway
Authors: Yi-Pin CAI, Yu HUANG, Jie ZHANG, Xiao-Li LIU, Fang ZHAO, Kuan ZHANG, Song-Yuan XU, Yan YANG, Hai-Wei HUANG, Yu GAO
Neoplasma Vol.69, No.6, p. 1406–1417, 2022
doi:10.4149/neo_2022_220730N784
Price: free access
[View Abstract]


Stanniocalcin1 knockdown induces ferroptosis and suppresses glycolysis in prostate cancer via the Nrf2 pathway
Authors: Yuan-Qing DAI, Yao BAI, Jie GU, Ben-Yi FAN
Neoplasma Vol.69, No.6, p. 1396–1405, 2022
doi:10.4149/neo_2022_220626N665
Price: free access
[View Abstract]


GDF11 knockdown downregulates SMURF1 to inhibit breast cancer progression by activation of p53 and inactivation of ERα signaling
Authors: Hai-Li TANG, Qi WANG, Jian-Guo LU, Xiao-Jun YANG, Jiao-Jiao SHI, Sheng-Peng WANG, Chang-Qing CAO, Hua-Dong ZHAO
Neoplasma Vol.69, No.6, p. 1386–1395, 2022
doi:10.4149/neo_2022_220607N601
Price: free access
[View Abstract]


SUMO1-modified DNA methyltransferase 1 induces DNA hypermethylation of VWC2 in the development of colorectal cancer
Authors: Xiao-Hu Cheng, Tong-Tong Xu, Lian-Bang Zhou, Fang-Yuan Li, Song Wang, Huan-Ru Liang, Jing-Jing Tang, Chang-Qin Duan, Heng Jiang, Ying-Feng Zhang, Zhi-Ning Liu
Neoplasma Vol.69, No.6, p. 1373–1385, 2022
doi:10.4149/neo_2022_220817N841
Price: free access
[View Abstract]


miR-550a-5p promotes the proliferation and migration of hepatocellular carcinoma by targeting GNE via the Wnt/β-catenin signaling pathway
Authors: Chun-Ming Li, Wu Wu, Zhu Zhu, Pei-Lin Lu, Jian-Ping Gong, Rong Ma
Neoplasma Vol.69, No.6, p. 1359–1372, 2022
doi:10.4149/neo_2022_220727N774
Price: free access
[View Abstract]


PHF21A expression as a biomarker of hepatocellular carcinoma progression and prognosis
Authors: Jia-Qing Huang, Li-Chen Ji, Qian-Gan Jing, Yi-Chen He, Ying-Yu Ma, Xiang-Min Tong
Neoplasma Vol.69, No.6, p. 1349–1358, 2022
doi:10.4149/neo_2022_220807N806
Price: free access
[View Abstract]


PRKAA1, stabilized by FTO in an m6A-YTHDF2-dependent manner, promotes cell proliferation and glycolysis of gastric cancer by regulating the redox balance
Authors: Yangmei Zhang, Xichang Zhou, Xue Cheng, Xiou Hong, Xiaowei Jiang, Guilong Jing, Kai Chen, Yang Li
Neoplasma Vol.69, No.6, p. 1338–1348, 2022
doi:10.4149/neo_2022_220714N714
Price: free access
[View Abstract]


Functions of long non-coding RNA LNC11649 in non-small cell lung cancer cells as a reprocessed form of MALAT1
Authors: Jun-Zhe Qi, Ting-Ting Zhao, Shu-Shan Qi
Neoplasma Vol.69, No.6, p. 1322–1337, 2022
doi:10.4149/neo_2022_220705N689
Price: free access
[View Abstract]


Mutational landscape of DNA damage response deficiency-related genes and its association with immune biomarkers in esophageal squamous cell carcinoma
Authors: Gang Chen, Yong-Jun Zhu, Ji Chen, Feng Miao, Ning Wu, Yang Song, Bei-Bei Mao, Sheng-Zhou Wang, Fei Xu, Zhi-Ming Chen
Neoplasma Vol.69, No.6, p. 1314–1321, 2022
doi:10.4149/neo_2022_220721N738
Price: free access
[View Abstract]


HOXC10 indicates poor survival outcome in gastric cancer and promotes G1/S cell cycle transition through transcriptional repression of p21
Authors: Zheng-Hua Lin, Jia-Min He, San-Chuan Lai, Ning Ding, Ying Jiang, Xing-Kang He, Xiao-Sun Liu, Zhi-Hui Huang
Neoplasma Vol.69, No.6, p. 1303–1313, 2022
doi:10.4149/neo_2022_220609N615
Price: free access
[View Abstract]





Display #  
Results 1 - 20 of 145

© AEPress s.r.o
Copyright notice: For any permission to reproduce, archive or otherwise use the documents in the ELiS, please contact AEP.